Aurélien Bourquard

Chief data scientist and cofounder at Leuko, a company that spun out from the Massachusetts Institute of Technology (MIT) and the Madrid–MIT M+Visión Consortium.
With a professional background in micro-engineering, biomedical engineering, signal processing and image processing, Aurélien has strong research interests in biomedical imaging, inverse problems, algorithm design, computational optics, holography, and statistical modeling. He received his MSc degree in microengineering from the École Polytechnique Fédérale de Lausanne (EPFL), Switzerland, and his PhD with the Biomedical Imaging Group, EPFL. After working as a postdoctoral research fellow at the MIT and the Technical University of Madrid (UPM), Carlos
Castro-Gonzalez, Ian Butterworth, Álvaro Sánchez-Ferro and Aurélien himself co-founded Leuko and co-invented Leuko’s proprietary PointCheck™ technology for non-invasive white blood cell monitoring, in order to improve the quality of life and outcomes for chemotherapy patients and others at risk of sever neutropenia.